Gene splicing gone wrong leads to aggressive medulloblastoma
Disturbing OTX2’s gene-splicing ability reduced tumor growth, opening possibilities for improved treatments.
Read More
A potential new therapeutic target for Group 3 medulloblastoma
Researchers identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma in the developing brain.
Read More
CAR T cell therapy for pediatric brain cancer warrants further study
This study shows that this therapy can effectively get to the tumor, and the addition of C7R safely augments antitumor activity.
Read More